Wellma joins forces with Fipros A/S, a leading CDMO in the Nordics, specialized in gels and powders

Stockholm, Sweden – Wellma, one of the fastest growing European development and manufacturing companies for nutraceuticals and pharmaceuticals, is proud to announce its strategic partnership with Fipros A/S, a Danish CDMO specialized in powders and gels. Fipros A/S operates from two sites, one specialized in gels and one on powders. This strategic move expands Wellma’s footprint in Northern Europe while growing Wellma’s presence and capabilities in important and growing formats.

Founded in 1992 and headquartered in Funen, Denmark, Fipros A/S has grown into a trusted partner serving more than 150 customers globally. Over the past three decades, the company has expanded from its roots in food processing to become a specialist in nutraceutical powders and gels, supported by strong investments in advanced production technology, automation, and digitalization. With modern facilities certified to international quality standards, Fipros A/S combines long-standing industry expertise with cutting-edge innovation within specialty food and nutraceutical development and production.

“Wellma shares our entrepreneurial spirit and strong commitment to quality, making this a natural match.” said Conny Twisttmann, CEO of Fipros A/S. “Together, we can offer even greater value to our customers and employees by leveraging the strength of the full Wellma ecosystem. This is an exciting next chapter where we can continue to be who we are, while becoming even better together with Wellma”

Morten Duch, Innovation & Sales Director at Fipros A/S, continued: “From the beginning, we saw a strong alignment between Fipros A/S and Wellma, and this partnership opens new opportunities to bring our technology and expertise to more markets. We look forward to continuing our journey, building on our strengths while growing together with Wellma”

Christian Merup, CEO of Wellma, added: “We have been very impressed by Fipros’s journey and their development and production capabilities since the moment we got to know each other. They always put their customers first, and have a high focus on innovation, quality and technology. Over the last few years, we have built up a strong relationship together, and we are excited to team up with Morten, Conny, and the full team at Fipros A/S. They perfectly represent the values we look for: entrepreneurship, deep expertise, focus on the customer and a strong willingness to grow not only Fipros A/S, but the full Wellma ecosystem. They also bring market-leading knowledge within automation and robotics, having developed state-of-the-art production technologies to serve complex formulations in powders and gels. This makes them a natural and highly valuable addition to the Wellma family.”

With the addition of Fipros A/S, Wellma further strengthens its position as one of Europe’s leading CDMO platforms in nutraceuticals and pharmaceuticals, uniting a network of specialized sites and entrepreneurs to deliver excellence across formats and geographies.

About Wellma

Wellma is a European leader in development and co-manufacturing of nutraceuticals and pharmaceuticals. Through a unique ecosystem of specialized sites across Europe, Wellma provides end-to-end services across all formats including powders, tablets, capsules, gummies, gels, and liquids. Headquartered in Stockholm, Wellma partners with innovative brands worldwide to deliver quality, flexibility, and speed to market.

About Fipros A/S

Founded in 1992 and headquartered in Funen, Denmark, Fipros A/S is a CDMO specialized in powders and gels for the nutraceutical and food industries. With two Danish production sites, advanced automation, and certifications including FSSC 22000, FDA, and GACC, Fipros A/S serves more than 150 global customers with innovative and high-quality solutions.

For media inquiries or further information, please contact: michael@wellma.com

For more information, visit: www.wellma.com